Birth control pills, patch, or ring

References

Citations

1. Kaunitz AM (2001). Oral contraceptive use in perimenopause. American Journal of Obstetrics and Gynecology, 185(2, Suppl): S32–S37.

2. Rapkin AJ, et al. (2002). The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Current Psychiatry Reports, 4(6): 419–428.

3. Hatcher RA, et al. (2004). Combined (estrogen and progestin) contraceptives. In A Pocket Guide to Managing Contraception, pp. 97–119. Tiger, GA: Bridging the Gap Foundation.

4. Ehrmann DA (2005). Polycystic ovary syndrome. New England Journal of Medicine, 352(12): 1223–1236.

5. Abramowicz M (2004). Choice of contraceptives. Treatment Guidelines From the Medical Letter, 2(24): 55–62.

6. Fraser IS, Kovacs GT (2003). The efficacy of non-contraceptive uses of hormonal contraceptives. Medical Journal of Australia, 178(12): 621–623.

7. Yonkers KA, et al. (2005). Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstetrics and Gynecology, 106(3): 492–501.

8. Zieman M, et al. (2007). Managing Contraception for Your Pocket. Tiger, GA: Bridging the Gap Foundation.

9. Hatcher RA, Nelson A (2004). Combined hormonal contraceptive methods. In RA Hatcher et al., eds., Contraceptive Technology, 18th ed., pp. 391–460. New York: Ardent Media.

Author:	Bets Davis, MFA	Last Updated: August 16, 2007
Medical Review:	Joy Melnikow, MD, MPH - Family Medicine Kirtly Jones, MD - Obstetrics and Gynecology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.